US Patent 9260711 Solid matrix for one step nucleic acid amplification
Patent 9260711 was granted and assigned to GE Healthcare on February, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Article (+280 characters)
Article
Patent abstract
The present invention to relates to methods and kits which can be used to amplify nucleic acids with the advantage of decreasing user time and possible contamination. The PCR reagents are bound to a solid matrix for easy processing and amplification of DNA samples.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Cheryl L. Potts0
Kathryn L. Lamerton0
Michael K. Kenrick0
Simon L. Stubbs0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09260711 Solid matrix for one step nucleic acid amplification US Patent 9260711 Solid matrix for one step nucleic acid amplification
Infobox
Patent Number
09260711
Patent Number
9260711
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09260711 Solid matrix for one step nucleic acid amplification
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09260711
Date of patent
February 16, 2016
Patent application number
13799174
Date Filed
March 13, 2013
Patent primary examiner
Find more entities like US Patent 9260711 Solid matrix for one step nucleic acid amplification
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.